Literature DB >> 11666388

Chemical and Biological Studies of Dichloro(2-((dimethylamino)methyl)phenyl)gold(III).

Richard V. Parish1, Brian P. Howe, Jonathan P. Wright, Jürgen Mack, Robin G. Pritchard, Robert G. Buckley, Amanda M. Elsome, Simon P. Fricker.   

Abstract

Several new organogold(III) derivatives of the type [AuX(2)(damp)] (damp = o-C(6)H(4)CH(2)NMe(2)) have been prepared [X = CN, SCN, dtc, or X(2) = tm; dtc = R(2)NCS(2) (R = Me (dmtc) or Et (detc)); tm = SCH(CO(2))CH(2)CO(2)Na] together with [AuCl(tpca)(damp)]Cl (tpca = o-Ph(2)PC(6)H(4)CO(2)H), [Au(dtc)(damp)]Y (Y = Cl, BPh(4)) and K[Au(CN)(3)(damp)]. The (13)C NMR spectra of these and previous derivatives have been fully assigned. In [Au(dtc)(2)(damp)] and K[Au(CN)(3)(damp)], the damp ligand is coordinated only through carbon, as shown by X-ray crystallography and/or NMR. [Au(detc)(2)(damp)] has space group C2/c, with a = 29.884(4) Å, b = 13.446(2) Å, c = 12.401(2) Å, beta = 99.45(3)(o), V = 4915 Å(3), Z = 8, and R = 0.057 for 1918 reflections. The damp and one detc ligand are monodentate, the other detc is bidentate; in solution, the complex shows dynamic behavior, with the detc ligands appearing equivalent. The crystal structure of [Au(dmtc)(damp)]BPh(4) [Pna2(1), a = 26.149(5) Å, b = 11.250(2) Å, c = 11.921(2) Å, V = 3507 Å(3), Z = 4, R = 0.073, 1772 reflections] shows both ligands to be bidentate in the cation, but the two Au-S distances are nonequivalent. The crystal structure of [Au(tm)(damp)] has also been determined [P2(1)/n, a = 18.267(7) Å, b = 9.618(3) Å, c = 18.938(4) Å, beta = 113.45(3)(o), V = 3053 Å(3), Z = 8, R = 0.079, 1389 reflections]. The tm is bound through sulfur and the carboxyl group which allows five-membered ring formation. In all three structures, the trans-influence of the sigma-bonded aryl group is apparent. [AuCl(2)(damp)] has been tested in vitroagainst a range of microbial strains and several human tumor lines, where it displays differential cytotoxicity similar to that of cisplatin. Against the ZR-75-1 human tumor xenograft, both [AuCl(2)(damp)] and cisplatin showed limited activity.

Entities:  

Year:  1996        PMID: 11666388     DOI: 10.1021/ic950343b

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

Review 1.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

2.  Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets.

Authors:  Neha Shaik; Alberto Martínez; Idline Augustin; Hugh Giovinazzo; Armando Varela-Ramírez; Mercedes Sanaú; Renato J Aguilera; María Contel
Journal:  Inorg Chem       Date:  2009-02-16       Impact factor: 5.165

3.  Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study.

Authors:  Angela Casini; Gerhard Kelter; Chiara Gabbiani; Maria Agostina Cinellu; Giovanni Minghetti; Dolores Fregona; Heinz-Herbert Fiebig; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-06-20       Impact factor: 3.358

4.  Grafting of a novel gold(III) complex on nanoporous MCM-41 and evaluation of its toxicity in Saccharomyces cerevisiae.

Authors:  Yousef Fazaeli; Mostafa M Amini; Hamed Ashourion; Homayoun Heydari; Abbas Majdabadi; Amir Reza Jalilian; Shamsozoha Abolmaali
Journal:  Int J Nanomedicine       Date:  2011-12-12

Review 5.  Gold-Derived Molecules as New Antimicrobial Agents.

Authors:  Carlos Ratia; Raquel G Soengas; Sara M Soto
Journal:  Front Microbiol       Date:  2022-03-23       Impact factor: 5.640

6.  A CS-Cyclometallated Gold(III) Complex as a Novel Antibacterial Candidate Against Drug-Resistant Bacteria.

Authors:  Carlos Ratia; Virginio Cepas; Raquel Soengas; Yolanda Navarro; María Velasco-de Andrés; María José Iglesias; Francisco Lozano; Fernando López-Ortiz; Sara M Soto
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

Review 7.  Gold (III) Derivatives in Colon Cancer Treatment.

Authors:  Agata Gurba; Przemysław Taciak; Mariusz Sacharczuk; Izabela Młynarczuk-Biały; Magdalena Bujalska-Zadrożny; Jakub Fichna
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.